Exploring the origins of grey matter damage in multiple sclerosis

Calabrese, Massimiliano, Magliozzi, Roberta, Ciccarelli, Olga, Geurts, Jeroen J. G., Reynolds, Richard, Martin, Roland·2015·Nature Reviews Neuroscience

DOI 10.1038/nrn3900

Cited by (413)

Items 101–200 of 413

Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview
Giuseppe Scalabrino · 2020 · Cellular and Molecular Neurobiology
Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15
Lukas Enz, Thomas Zeis, Daniela Schmid, Florian M. Geier, Franziska van der Meer, Guido Steiner, Ulrich Certa, Thomas M. C. Binder, Christine Stadelmann, Roland Martinꝉ et al. · 2019 · Neurology Neuroimmunology & Neuroinflammation
Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
Ahmed Abdelhak, Martin S. Weber, Hayrettin Tumani · 2017 · Frontiers in Neurology
Formation and immunomodulatory function of meningeal B cell aggregates in progressive CNS autoimmunity
Meike Mitsdoerffer, Giovanni Di Liberto, Sarah Dötsch, Christopher Sie, Ingrid Wagner, Monika Pfaller, Mario Kreutzfeldt, Simon P. Fräßle, Lilian Aly, Benjamin Knier et al. · 2021 · Brain
Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis
Marco Puthenparampil, Lisa Federle, Davide Poggiali, Silvia Miante, Alessio Signori, Elisabetta Pilotto, Francesca Rinaldi, Paola Perini, Maria Pia Sormani, Edoardo Midena et al. · 2017 · PLoS ONE
Fingolimod inhibits brain atrophy and promotes brain-derived neurotrophic factor in an animal model of multiple sclerosis
Paul A. Smith, Cindy Schmid, Stefan Zurbruegg, Magali Jivkov, Arno Doelemeyer, Diethilde J Theil, Valérie Dubost, Nicolau Beckmann · 2018 · Journal of Neuroimmunology
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
Matteo Bauckneht, Selene Capitanio, Stefano Raffa, Luca Roccatagliata, Matteo Pardini, Caterina Lapucci, Cecilia Marini, Gianmario Sambuceti, Matilde Inglese, Paolo Gallo et al. · 2019 · EJNMMI Radiopharmacy and Chemistry
CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis
Michael R. Mazzucco, William Mannheim, Samantha V. Shetty, Jennifer R. Linden · 2022 · Fluids and Barriers of the CNS
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration
Rachel E James Bates, Eleanor Browne, Renée Schalks, Heather Jacobs, Li Yi Tan, Puja Parekh, Roberta Magliozzi, Massimiliano Calabrese, Nicholas D. Mazarakis, Richard Reynolds · 2022 · Brain
Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study
Tom A. Fuchs, Stefano Ziccardi, Michael G. Dwyer, Leigh Elkins Charvet, Alexander Bartnik, Rebecca Campbell, Jose Escobar, David W. Hojnacki, Chana Kolb, Devon Oship et al. · 2019 · Multiple Sclerosis and Related Disorders
Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis
Giulia Menculini, Elena Chipi, Federico Paolini Paoletti, Lorenzo Gaetani, Pasquale Nigro, Simone Simoni, Andrea Mancini, Nicola Tambasco, Massimiliano Di Filippo, Alfonso Antonio Vincenzo Tortorella et al. · 2021 · International Journal of Molecular Sciences
Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach
Giuseppe Pontillo, Simone Penna, Sirio Cocozza, Mario Quarantelli, Michela Gravina, Roberta Lanzillo, Stefano Marrone, Teresa Costabile, Matilde Inglese, Vincenzo Brescia Morra et al. · 2022 · European Radiology
Changes in brain functional connectivity patterns are driven by an individual lesion in MS: a resting-state fMRI study
Amgad Droby, Kenneth S.L. Yuen, Muthuraman Muthuraman, Sarah Christina Reitz, Vinzenz Fleischer, Johannes Christian Klein, René‐Maxime Gracien, Ulf Ziemann, Ralf Deichmann, Frauke Zipp et al. · 2015 · Brain Imaging and Behavior
Distinctive Structural and Molecular Features of Myelinated Inhibitory Axons in Human Neocortex
Kristina D. Micheva, Edward F. Chang, Alissa L. Nana, William W. Seeley, Jonathan T. Ting, Charles Cobbs, Ed S. Lein, Stephen J Smith, Richard J. Weinberg, Daniel V. Madison · 2018 · eNeuro
Astrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis
Pennelope K. Blakely, Shabbir Hussain, Lindsey E. Carlin, David N. Irani · 2015 · Frontiers in Neuroscience
Assessing disease progression and treatment response in progressive multiple sclerosis
Gıancarlo Comı, Gloria Dalla Costa, Bruno Stankoff, Hans‐Peter Hartung, Per Soelberg Sørensen, Patrick Vermersch, Letizia Leocani · 2024 · Nature Reviews Neurology
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Vinzenz Fleischer, Nabin Koirala, Amgad Droby, René‐Maxime Gracien, Ralf Deichmann, Ulf Ziemann, Sven Guenther Meuth, Muthuraman Muthuraman, Frauke Zipp, Sergiu Groppa · 2019 · Therapeutic Advances in Neurological Disorders
MRI phenotypes in MS
Christopher C. Hemond, Brian C. Healy, Shahamat Tauhid, Maria Antonietta Mazzola, Francisco Javier Quintana, Roopali Gandhi, Howard L. Weiner, Rohit Bakshi · 2019 · Neurology Neuroimmunology & Neuroinflammation
Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy
Martijn D. Steenwijk, Houshang Amiri, Menno Michiel Schoonheim, Alexandra de Sitter, Frederik Barkhof, Petra J. W. Pouwels, Hugo Vrenken · 2017 · NeuroImage Clinical
CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
Damiano Marastoni, Roberta Magliozzi, Anna Bolzan, Anna Isabella Pisani, Stefania Rossi, Francesco Crescenzo, Stefania Montemezzi, Francesca Benedetta Pizzini, Massimiliano Calabrese · 2021 · Neurology Neuroimmunology & Neuroinflammation
Understanding multiple sclerosis as a disease spectrum: above and below the clinical threshold
Stephen C. Krieger, Karin Cook, Carrie M. Hersh · 2024 · Current Opinion in Neurology
T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosis
Ivan Jelčić, Reza Naghavian, Imran Fanaswala, Will Macnair, Cinzia Esposito, Daniela Calini, Yanan Han, Zoe Marti, Catarina Raposo, Jacobo Sarabia del Castillo et al. · 2025 · Cell Reports Medicine
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients
Elisabeth Solana, Eloy Martínez‐Heras, Víctor Montal, Eduard Vilaplana, Elisabet López-Soley, Joaquim Raduà, Núria Solà‐Valls, Carmen Montejo, Yolanda Blanco, Irene Pulido-Valdeolivas et al. · 2021 · Scientific Reports
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis
Andrea Mancini, Michela Tantucci, Petra Mazzocchetti, Antonio de Iure, Valentina Durante, Lara Macchioni, Carmela Giampà, Alessandra Alvino, Lorenzo Gaetani, Cinzia Costa et al. · 2018 · Neurobiology of Disease
B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans
Angela A. Wang, Felix Luessi, Tradite Neziraj, Elisabeth Pössnecker, Michelle Zuo, Sinah Engel, Nicholas Hanuscheck, Alexandra Florescu, Eryn Bugbee, I. Xianjie et al. · 2024 · Science Translational Medicine
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis
Roberta Magliozzi, Marco Pitteri, Stefano Ziccardi, Anna Isabella Pisani, Luigi Montibeller, Damiano Marastoni, Stefania Rossi, Valentina Mazziotti, Maddalena Guandalini, Caterina Dapor et al. · 2021 · Annals of Clinical and Translational Neurology
The quality of cortical network function recovery depends on localization and degree of axonal demyelination
Manuela Cerina, Venu Narayanan, Kerstin Göbel, Stefan Bittner, Tobias Ruck, Patrick Meuth, Alexander M. Herrmann, Martin Stangel, Viktoria Gudi, Thomas Skripuletz et al. · 2016 · Brain Behavior and Immunity
Progressive brain rich-club network disruption from clinically isolated syndrome towards multiple sclerosis
Ni Shu, Yunyun Duan, Jing Huang, Zhuoqiong Ren, Zheng Liu, Huiqing Dong, Frederik Barkhof, Kuncheng Li, Yaou Liu · 2018 · NeuroImage Clinical
Stromal cell niches in the inflamed central nervous system.
Pikor, Natalia B, Cupovic, Jovana, Onder, Lucas, Gommerman, Jennifer L, Ludewig, Burkhard · 2017 · The Journal of Immunology
Quantifying Remyelination Using χ-Separation in White Matter and Cortical Multiple Sclerosis Lesions
Jannis Müller, Po‐Jui Lu, Alessandro Cagol, Esther Ruberte, Hyeong‐Geol Shin, Mario Ocampo‐Pineda, Xinjie Chen, Charidimos Tsagkas, Muhamed Baraković, Riccardo Galbusera et al. · 2024 · Neurology
Linking immune-mediated damage to neurodegeneration in multiple sclerosis: could network-based MRI help?
Sergiu Groppa, Gabriel González‐Escamilla, Arman Eshaghi, Sven Guenther Meuth, Olga Ciccarelli · 2021 · Brain Communications
Synapse Dysfunctions in Multiple Sclerosis
Karin Schwarz, Frank Schmitz · 2023 · International Journal of Molecular Sciences
The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis
Jan Lycke, Henrik Zetterberg · 2017 · Expert Review of Clinical Immunology
A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?
Gerwyn Morris, Michael Berk, Basant K. Puri · 2017 · Molecular Neurobiology
Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
Lesley A. Ward, Dennis S. W. Lee, Anshu Kumar Sharma, Angela A. Wang, Ikbel Naouar, I. Xianjie, Natalia Barbara Pikor, Barbara Nuesslein‐Hildesheim, Valeria Ramaglia, Jennifer L. Gommerman · 2019 · JCI Insight
Age-dependent gray matter demyelination is associated with leptomeningeal neutrophil accumulation
Michelle Zuo, Naomi M. Fettig, Louis‐Philippe Bernier, Elisabeth Pössnecker, Shoshana Spring, Annie Pu, I. Xianjie, Dennis Sw Lee, Lesley A. Ward, Anshu Kumar Sharma et al. · 2022 · JCI Insight
HSV-1 and Endogenous Retroviruses as Risk Factors in Demyelination
Raquel Bello‐Morales, Sabina Andreu, Inés Ripa, José Antonio López‐Guerrero · 2021 · International Journal of Molecular Sciences
Early auto‐immune targeting of photoreceptor ribbon synapses in mouse models of multiple sclerosis
Mayur Dembla, Ajay Kesharwani, Sivaraman Natarajan, Claudia Fecher‐Trost, Richard Fairless, Sarah K. Williams, Veit Flockerzi, Ricarda Diem, Karin Schwarz, Frank Schmitz · 2018 · EMBO Molecular Medicine
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Valentina Mazziotti, Francesco Crescenzo, Ermanna Turano, Maddalena Guandalini, Maddalena Bertolazzo, Stefano Ziccardi, Federica Virla, Valentina Camera, Damiano Marastoni, Agnese Tamanti et al. · 2024 · Journal of Neuroinflammation
The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI
Céline Louapre, Sindhuja Tirumalai Govindarajan, Costanza Giannì, Nancy K. Madigan, Allen Scott Nielsen, Jacob A. Sloane, Revere Philip Kinkel, Caterina Mainero · 2016 · NeuroImage Clinical
New Prospects for Ultra-High-Field Magnetic Resonance Imaging in Multiple Sclerosis
Benjamin Victor Ineichen, Erin Beck, Marco Piccirelli, Daniel S. Reich · 2021 · Investigative Radiology
Structural magnetic resonance imaging findings and histopathological correlations in motor neuron diseases—A systematic review and meta-analysis
Charlotte Zejlon, Dominik Nakhostin, Sebastian F.-X. Winklhofer, Athina Pangalu, Zsolt Kulcsár, Sebastian A. Lewandowski, Johannes Finnsson, Fredrik Piehl, Caroline Ingre, Tobias Granberg et al. · 2022 · Frontiers in Neurology
Oxidative injury in multiple sclerosis cerebellar grey matter
Kevin C. Kemp, Juliana Redondo, Kelly M Hares, Claire M Rice, Neil J. Scolding, Alastair Wilkins · 2016 · Brain Research
Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models
Nina Wagenknecht, Birte Becker, Miriam Scheld, Cordian Beyer, Tim Clarner, Tanja Hochstrasser, Markus Kipp · 2016 · Journal of Molecular Neuroscience
Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts
Jonathan D. Zurawski, James M. Stankiewicz · 2017 · The American Journal of Medicine
Gray Matter Alterations in Early and Late Relapsing-Remitting Multiple Sclerosis Evaluated with Synthetic Quantitative Magnetic Resonance Imaging
Christina Andica, Akifumi Hagiwara, Koji Kamagata, Kazumasa Yokoyama, Keigo Shimoji, Asami Saito, Yuki Takenaka, Misaki Nakazawa, Masaaki Hori, Julien Cohen‐Adad et al. · 2019 · Scientific Reports
The relevance of cortical lesions in patients with multiple sclerosis
Olivia Geisseler, Tobias Pflugshaupt, Ladina Bezzola, Katja Reuter, David Weller, Bernhard Schuknecht, Peter Brugger, Michael Linnebank · 2016 · BMC Neurology
Sex differences and subclinical retinal injury in pediatric-onset MS
Jennifer Graves, Hardeep Chohan, Benjamin E. Cedars, Samuel Arnow, Hao Yiu, Emmanuelle L. Waubant, Ari Green · 2016 · Multiple Sclerosis Journal
Seizures as a clinical manifestation in somatic autoimmune disorders
Man Amanat, Roland D. Thijs, Mona Salehi, Josemir W. A. S. Sander · 2018 · Seizure
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons
Antonietta Gentile, Francesca De Vito, Diego Fresegna, Francesca Romana Rizzo, Silvia Bullitta, Livia Guadalupi, Valentina Vanni, Fabio Buttari, Mario Stampanoni Bassi, Alessandro Leuti et al. · 2019 · Neuropathology and Applied Neurobiology
In vivo imaging of CNS microglial activation/macrophage infiltration with combined [18F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis
Anna Rita Daniela Coda, Serenella Anzilotti, Francesca Boscia, Adelaide Greco, Mariarosaria Panico, Sara Gargiulo, Matteo Gramanzini, Antonella Zannetti, Sandra Albanese, Giuseppe Pignataro et al. · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
Colony-stimulating factor 1 receptor signaling in the central nervous system and the potential of its pharmacological inhibitors to halt the progression of neurological disorders
Tarale, Prashant, Alam, Mahabub Maraj · 2022 · Inflammopharmacology
Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives
Alberto Gajofatto, Marco Turatti, Maria Donata Benedetti · 2016 · Expert Review of Neurotherapeutics
Epilepsy as a predictor of disease progression in multiple sclerosis
Matthias Grothe, David Ellenberger, Felix von Podewils, Alexander Stahmann, Paulus Stefan Rommer, Uwe Klaus Zettl · 2021 · Multiple Sclerosis Journal
Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables
Marco Pitteri, Roberta Magliozzi, Albulena Bajrami, Valentina Camera, Massimiliano Calabrese · 2018 · Expert Opinion on Pharmacotherapy
The impact of deep grey matter volume on cognition in multiple sclerosis
Lorena Lorefice, Elisa Carta, Jessica Frau, Franco Contu, Elisa Casaglia, Giancarlo Coghe, Maria Antonietta Barracciu, Eleonora E. Cocco, Giuseppe Fenu · 2020 · Multiple Sclerosis and Related Disorders
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody‐associated Disease, Aquaporin‐4 Antibody‐Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis
Rosa Cortese, Marco Battaglini, Ferrán Prados, Giordano Gentile, Ludovico Luchetti, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline A. Palace, Silvia Messina et al. · 2024 · Annals of Neurology
Conventional MRI-Based Structural Disconnection and Morphometric Similarity Networks and Their Clinical Correlates in Multiple Sclerosis
Mario Tranfa, Maria Petracca, Marcello Moccia, Alessandra Scaravilli, Frederik Barkhof, Vincenzo Brescia Morra, Antonio Carotenuto, Sara Collorone, Andrea Elefante, Fabrizia Falco et al. · 2025 · Neurology
Defining Disease Activity and Response to Therapy in MS
Ulrike W. Kaunzner, Mais Al‐Kawaz, Susan A. Gauthier · 2017 · Current Treatment Options in Neurology
Dynamics of pseudo‐atrophy in RRMS reveals predominant gray matter compartmentalization
Nicola De Stefano, Antonio Giorgio, Giordano Gentile, Maria Laura Stromillo, Rosa Cortese, Claudio Gasperini, Andrea Visconti, Maria Pia Sormani, Marco Battaglini · 2021 · Annals of Clinical and Translational Neurology
Innate immune cell-related pathology in the thalamus signals a risk for disability progression in multiple sclerosis
Misin, Olavi, Matilainen, Markus, Nylund, Marjo, Honkonen, Eveliina, Rissanen, Eero, Sucksdorff, Marcus, Airas, Laura · 2022 · Neurology Neuroimmunology & Neuroinflammation
The Effect of Counseling Based on EX-PLISSIT Model on Sexual Dysfunction and Quality of Sexual Life of Married Women with Multiple Sclerosis: A Randomized Controlled Clinical Trial
Roya Azari-Barzandig, Niloofar Sattarzadeh-Jahdi, Roghaiyeh Nourizadeh, Jamileh Malakouti, Saeed Mousavi, Gasem Dokhtvasi · 2020 · Sexuality and Disability
Imaging and depression in multiple sclerosis: a historical perspective
Fabio Giuseppe Masuccio, Giulia Gamberini, Massimiliano Calabrese, Claudio Marcello Solaro · 2021 · Neurological Sciences
Prospective memory impairment in multiple sclerosis: a review
Isabelle Rouleau, Emmanuelle Dagenais, Alexandra Tremblay, Mélanie Demers, Élaine Roger, Céline Jobin, Pierre Duquette · 2017 · The Clinical Neuropsychologist
Multiple sclerosis pathogenesis: missing pieces of an old puzzle
Reza Rahmanzadeh, Wolfgang Brück, Alireza Minagar, Mohammad Ali Sahraian · 2018 · Reviews in the Neurosciences
Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis
Véronique Ferret-Sena, Carlos Capela, Armando Sena · 2018 · International Journal of Molecular Sciences
Lost in Classification: Lower Cognitive Functioning in Apparently Cognitive Normal Newly Diagnosed RRMS Patients
Marco Pitteri, Stefano Ziccardi, Caterina Dapor, Maddalena Guandalini, Massimiliano Calabrese · 2019 · Brain Sciences
White matter disturbances in phenylketonuria: Possible underlying mechanisms
Bruna Klippel Ferreira, Melissa Torres Rodrigues, Emilio Luiz STRECK, Gustavo C. Ferreira, Patrícia Fernanda Schuck · 2020 · Journal of Neuroscience Research
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study
Svenja Kiljan, Paolo Preziosa, Laura E. Jonkman, Wilma D. J. van de Berg, Jos W. R. Twisk, Petra J. W. Pouwels, Geert J. Schenk, Maria Assunta Rocca, Massimo Filippi, Jeroen J.G. Geurts et al. · 2020 · Multiple Sclerosis Journal
The Complex Interplay Between Trait Fatigue and Cognition in Multiple Sclerosis
Camille Guillemin, Émilie Lommers, Gaël Delrue, Elodie Gester, Pierre Maquet, Fabienne Collette · 2022 · Psychologica Belgica
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets
Rosa Cortese, Marco Battaglini, Maria Pia Sormani, Ludovico Luchetti, Giordano Gentile, Maira Inderyas, Nektaria Alexandri, Nicola De Stefano · 2022 · European Journal of Neurology
Localised grey matter atrophy in multiple sclerosis is network-based: a coordinate-based meta-analysis
Florence L. Chiang, Qian‐Yi Wang, Fang Frank Yu, Rebecca S. Romero, Susie Y. Huang, P. Mickle Fox, Bundhit Tantiwongkosi, Peter T. Fox · 2019 · Clinical Radiology
Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple Sclerosis
Sapir Dreyer-Alster, Aviva Gal, Anat Achiron · 2021 · Journal of Neuro-Ophthalmology
Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis
Rhian Evans, Lewis M. Watkins, Kristen Hawkins, Gabriella Santiago, Constantinos Demetriou, Michelle Naughton, Marie Dittmer, Mark I. Rees, Denise C. Fitzgerald, B. Paul Morgan et al. · 2023 · Frontiers in Cellular Neuroscience
Protective potential of dimethyl fumarate in a mouse model of thalamocortical demyelination
Manuela Cerina, Venu Narayanan, Anna Delank, Patrick Meuth, Stéphanie Graebenitz, Kerstin Göbel, Alexander M. Herrmann, Stefanie Albrecht, Thiemo Daldrup, Thomas Seidenbecher et al. · 2018 · Brain Structure and Function
Voxel‐Based quantitative MRI reveals spatial patterns of grey matter alteration in multiple sclerosis
Émilie Lommers, Camille Guillemin, Gilles Reuter, Eve Fouarge, Gaël Delrue, Fabienne Collette, Christian Degueldre, Evelyne Balteau, Pierre Maquet, Christophe L. M. Phillips · 2020 · Human Brain Mapping
Social Cognition in Multiple Sclerosis: A 3-Year Follow-Up MRI and Behavioral Study
Stefano Ziccardi, Marco Pitteri, Helen M. Genova, Massimiliano Calabrese · 2021 · Diagnostics
Diverse pathways to neuronal necroptosis in Alzheimer's disease
Anusha Jayaraman, Richard Reynolds · 2022 · European Journal of Neuroscience
Neurodegeneration in multiple sclerosis is a process separate from inflammation: No
Michael Hutchinson · 2015 · Multiple Sclerosis Journal
Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis
Marco Castellaro, Roberta Magliozzi, Alessandro Palombit, Marco Pitteri, Erica Silvestri, Valentina Camera, Stefania Montemezzi, Francesca Benedetta Pizzini, Alessandra Bertoldo, Richard Reynolds et al. · 2017 · American Journal of Neuroradiology
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis
Hyunwoo Lee, Kunio Nakamura, Sridar Narayanan, Robert A. Brown, Jacqueline M. Chen, Harold L. Atkins, Mark Steven Freedman, Douglas Lorne Arnold · 2017 · Multiple Sclerosis Journal
A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis
Fawad Yousuf, Sheena L. Dupuy, Shahamat Tauhid, Renxin Chu, Gloria Y. Kim, Subhash Tummala, Fariha Khalid, Howard L. Weiner, Tanuja Chitnis, Brian C. Healy et al. · 2017 · Journal of the Neurological Sciences
Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases
Serhat Vahip Okar, Francesca Fagiani, Martina Absinta, Daniel S. Reich · 2024 · Cellular and Molecular Life Sciences
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis
Francesca Gado, Maria Digiacomo, Marco Macchia, Simone Bertini, Clementina Manera · 2018 · Medicines
Gut Microbiota-Modulated Metabolomic Profiling Shapes the Etiology and Pathogenesis of Autoimmune Diseases
Yi-Wen Tsai, Jia-Ling Dong, Yun-Jie Jian, Shin‐Huei Fu, Ming‐Wei Chien, Yuwen Liu, Chao-Yuan Hsu, Huey‐Kang Sytwu · 2021 · Microorganisms
Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin
Giuseppe Pontillo, Maria Petracca, Serena Monti, Mario Quarantelli, Roberta Lanzillo, Teresa Costabile, Antonio Carotenuto, Fabio Tortora, Andrea Elefante, Vincenzo Brescia Morra et al. · 2022 · European Radiology
Neurodegenerative disorders share common features of “loss of function” states of a proposed mechanism of nervous system functions
Kunjumon I. Vadakkan · 2016 · Biomedicine & Pharmacotherapy
Vanin-1-Activated Fluorescent Probe for Real-Time In Vivo Imaging of Inflammatory Responses Across Multiple Tissue Types
Dianfeng Dai, Zhimin Zhang, Mo Ma, Jingkang Li, Siqi Zhang, Pinyi Ma, Daqian Song · 2025 · Analytical Chemistry
Leptin sustains spontaneous remyelination in the adult central nervous system
Ken Matoba, Rieko Muramatsu, Toshihide Yamashita · 2017 · Scientific Reports
HLA-DRB1*04:05 allele is associated with intracortical lesions on three-dimensional double inversion recovery images in Japanese patients with multiple sclerosis
Koji Shinoda, Takuya Matsushita, Yuri Nakamura, Katsuhisa Masaki, Ryo Yamasaki, Hiroo Yamaguchi, Osamu Togao, Akio Hiwatashi, Jun‐ichi Kira · 2017 · Multiple Sclerosis Journal
Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study
Futoshi Matsushita, Hirotaka Kida, Ken‐ichi Tabei, Chizuru Nakano, Keita Matsuura, Yuichiro Ii, Ryogen Sasaki, Akira Taniguchi, Yugo Narita, Masayuki Maeda et al. · 2018 · Brain and Behavior
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study
Stefano Ziccardi, Francesco Crescenzo, Maddalena Guandalini, Gulser Caliskan, Luigi Martinelli, Agnese Tamanti, Gian Marco Schiavi, Albulena Bajrami, Damiano Marastoni, Massimiliano Calabrese · 2024 · Brain Communications
Grey:white matter ratio at diagnosis and the risk of 10‐year multiple sclerosis progression
Marcello Moccia, Mario Quarantelli, Roberta Lanzillo, Sirio Cocozza, Antonio Carotenuto, Barbara Carotenuto, Bruno Alfano, Anna Prinster, Maria Triassi, A. Nardone et al. · 2016 · European Journal of Neurology
TSPO-PET Imaging to Assess Cerebral Microglial Activation in Multiple Sclerosis
Howard L. Weiner, Rohit Bakshi, Tarun Singhal · 2017 · Seminars in Neurology
Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study
Tom A. Fuchs, Keith Carolus, Ralph H. B. Benedict, Niels Bergsland, Deepa Preeti Ramasamy, Dejan Jakimovski, Bianca Weinstock‐Guttman, Amy F. Kuceyeski, Robert Zivadinov, Michael G. Dwyer · 2018 · American Journal of Neuroradiology
Gray Matter Matters: A Longitudinal Magnetic Resonance Voxel-Based Morphometry Study of Primary Progressive Multiple Sclerosis
Ted L. Rothstein · 2020 · Frontiers in Neurology
Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study
Athina Papadopoulou, Frederike Cosima Oertel, Claudia Chien, Joseph Kuchling, Hanna Gwendolyn Zimmermann, Nadja Siebert, Seyedamirhosein Motamedi, Marcus D' Souza, Susanna Asseyer, Judith Bellmann–Strobl et al. · 2021 · NeuroImage Clinical
Autoimmune inflammation triggers aberrant astrocytic calcium signaling to impair synaptic plasticity
Andrés M. Baraibar, Teresa Colomer, A. Moreno‐García, Ana Bernal‐Chico, Ester Sánchez-Martín, Cristina Utrilla, R. Serrat, Edgar Soria Gómez, Alfredo Rodríguez-Antigüedad, Alfonso Araque et al. · 2024 · Brain Behavior and Immunity
Random number generation deficits in patients with multiple sclerosis: Characteristics and neural correlates
Olivia Geisseler, Tobias Pflugshaupt, Andreas Buchmann, Ladina Bezzola, Katja Reuter, Bernhard Schuknecht, David Weller, Michael Linnebank, Peter Brugger · 2016 · Cortex
A Scope of the Social Brain in Multiple Sclerosis: Insights From Neuroimaging Studies
Moussa A. Chalah, Samar S. Ayache · 2020 · Cognitive and Behavioral Neurology